癌变·畸变·突变 ›› 2026, Vol. 38 ›› Issue (1): 22-26.doi: 10.3969/j.issn.1004-616x.2026.01.004

• 论著 • 上一篇    

TCT联合高危型HPV检测对社区绝经后妇女机会性宫颈癌筛查的应用价值

尹璐1, 张志亮2, 张琳1, 叶兰1   

  1. 1. 上海市普陀区妇婴保健院妇产科, 上海 200062;
    2. 上海市普陀区桃浦镇社区卫生服务中心妇科, 上海 200331
  • 收稿日期:2025-03-26 修回日期:2025-10-23 发布日期:2026-01-30
  • 通讯作者: 叶兰
  • 基金资助:
    上海市普陀区卫生健康系统科技创新项目(ptkwws202405)

Usefulness of thin-prep cytologic test combined with high-risk human papilloma virus detection in opportunistic screening for cervical cancer in postmenopausal women

YIN Lu1, ZHANG Zhiliang2, ZHANG Lin1, YE Lan1   

  1. 1. Department of Obstetrics and Gynecology, Putuo Maternity and Child Healthcare Hospital of Shanghai, Shanghai 200062;
    2. Department of Gynecology, Putuo Taopu Town Community Health Service Center of Shanghai, Shanghai 200331, China
  • Received:2025-03-26 Revised:2025-10-23 Published:2026-01-30

摘要: 目的: 探讨宫颈液基薄层细胞学检测(TCT)联合高危型人乳头瘤病毒(HR-HPV)检测在社区绝经后妇女机会性宫颈癌筛查中的应用价值。方法: 收集2021年11月—2024年12月在上海市普陀区卫生服务中心行机会性宫颈癌筛查的698名绝经后妇女的临床资料,纳入对象均行TCT、HR-HPV检测,筛查结果异常者于上级医院行阴道镜检查165名。最终以阴道镜活检病理诊断为金标准,对TCT、HR-HPV检测及两者联合检测的灵敏度、特异度、准确度等进行比较,采用受试者工作特征(ROC)曲线分析诊断效能。结果: TCT和HR-HPV检测的灵敏度分别为91.11%和92.22%,特异度均为48.0%,阳性预测值为67.77%和68.03%,阴性预测值为81.82%和83.72%,准确度为71.52%和72.12%;两者联合检测的灵敏度为97.78%,特异度为45.33%,阳性预测值为68.22%,阴性预测值为94.44%,准确率为73.94%。TCT和HR-HPV联合检测筛查宫颈癌的准确度和ROC曲线下面积均高于TCT或HPV (P<0.05)。结论: TCT联合HR-HPV检测筛查具有较高的诊断效能,可提升宫颈癌筛查的灵敏度,对绝经后妇女机会性宫颈癌筛查有较高的临床应用价值。

关键词: 绝经后妇女, 宫颈癌, 机会性筛查, 宫颈液基薄层细胞检测, 高危型人乳头状瘤病毒, 联合筛查

Abstract: OBJECTIVE: To investigate the usefulness of thin-prep cytologic test (TCT) combined with high-risk human papilloma virus (HR-HPV) detection in opportunistic screening for cervical cancer in community postmenopausal women. METHODS: The clinical data of 698 community postmenopausal women who underwent opportunistic screening for cervical cancer from November 2021 to December 2024 were collected in this study, and these women were given TCT and HR-HPV detection. Among them, 165 individuals with abnormal screening results underwent colposcopy at a higher-level hospital. Finally, the sensitivity, specificity and accuracy of TCT, HR-HPV and their combined detection were compared and analyzed with colposcopy biopsy as the gold standard. The receiver operating characteristic (ROC) curve was used to analyze diagnostic performance. RESULTS: The sensitivities of TCT and HR-HPV testing were 91.11% and 92.22%,respectively,both with a specificity of 48.0%,positive predictive values of 67.77% and 68.03% , negative predictive values of 81.82% and 83.72% , and accuracies of 71.52% and 72.12% . The combined detection sensitivity of the two methods was 97.78% , specificity was 45.33% , positive predictive value was 68.22%,negative predictive value was 94.44%,and accuracy was 73.94%. The accuracy of TCT and HR-HPV testing alone was lower than that of the combined testing;the area under the ROC curve for combined testing in cervical cancer screening was higher than that of TCT or HPV alone (P<0.05). CONCLUSION: TCT combined with HR-HPV detection showed high diagnostic efficacy,improved sensitivity of cervical cancer screening, and higher clinical value for opportunistic cervical cancer screening in postmenopausal women.

Key words: postmenopausal women, cervical cancer, opportunistic screening, thin-layer liquid-based cytology test, high-risk human papillomavirus, combined screening

中图分类号: